iGenX Cancer Genetics Research

Research - Education - Treatment

About Me


Together we will beat Cancer

Juel 2
I am Dr. Juel CHowdhury, M.D. I have had the opportunity to work for oncology research with James A Radosvich, PhD on nitric oxide on cancer stem cells, and have had so many fulfilling experiences. Through these experiences, I’ve been able to work on some amazing projects with amazing people. Cancer has been prevalent all over the world, so I am proud to give such a great contribution that works to eliminate all types of cancer

About Us- What We Do


Oncology Project




Completed Research




Who We Are?

In the 1970s, less than a quarter of people with cancer survived. But over the last 40 years, survival has doubled.

Our ambition is to accelerate progress and see three-quarters of people surviving the disease within the next 20 years.

We want survival in the USA to be among the best in the world. We’re focusing our efforts in four key areas – working to help prevent cancer, diagnose it earlier, develop new treatments and optimise current treatments by personalising them and making them even more effective.

We’ll continue to support research into all types of cancer and across all age groups. And we’re keeping our focus on understanding the biology of cancer so we can use this vital knowledge to save more lives.

We’re increasing our research in key areas such as early diagnosis, and hard-to-treat cancers including lung, pancreatic, oesophageal cancers and brain tumours.

We’re developing new tests, surgery and radiotherapy techniques, and cancer drugs. We want to personalise prevention, screening and treatment and bring benefits to patients sooner.

Head & Neck Cancer
Oral Cancer
Lung Cancer
Liver Cancer

Meet The Team

James A Radosevich, Ph.D.

Oncology Researcher

Dr. Juel Chowdhury, M.D.

Oncology Researcher

Dr. John Adrien Thomas, MD

Oncology Researcher

Mahsa Vahdatian



Sponsoring ISOBM 2016 Congress Chicago

Being a doctor and researcher it is very important to help the cancer society. I am honored and previlaged that i could sponsor and actively take part in the 43rd ISOBM annual congress of Internatinal Society of Oncology and Biomarkers (ISOBM) which will take place in chicago from september 1st-6th, […]

6 April 2016 0

Childrens Day Event Special Guest

It was my please to be part of the childrens day event held in Albany park libray chicago, IL. Thank you Honorary Counsul of Bangladesh, Mr. Monir Chowdhury for the invitation. The event was full of enthusiam and positive spirit for the everyone. I was honored to deliver the health awareness […]

3 April 2016 0

Greater Together, We Can End Hunger

Sponsorship helps children, families, and communities break the cycle of poverty. Humanitarian mission dedicated to working with children, families, and their communities worldwide to reach their full potential by tackling the causes of poverty and injustice. We serve alongside the poor and oppressed as a demonstration of love for all […]

Our Focus


Our dedication to cancer reserach support innovative approaches for early diagnosis and treatment of various cancers.

Original Ideas

We are currently working on gene expression of various genes from the gene pool data analysis to figureout reasons for cancer development.  

Beat Cancer

Time is shortening. But every day that our reasearch work challenges cancer and every single survivor is a victory for us.


Childhood hunger is a major problem in many countries, but it is solvable. Donate to feed hungry kids.

We Proudly Support



My Resume

Dr.Juel Chowdhury MD


Juel Chowdhury began his professional education at the Gulf Medical University, UAE where he received his first professional degree in medicine (Doctor of Medicine). Since then, his works have led him to exchange scientific ideas with Nobel laureate Dr. Ferid Murad and many well-known scientists such as Dr. Robert Winn Director of UI health Chicago. He is the founder and president of Oncomarks.org an online professional network with an open access journal for the oncologists. His innovative iGenX lab is a gene research lab based on data-mining and data analysis of the various gene-chip experiments. Dr. Chowdhury is also proficient in several languages and computer programs. Reviewer of well-known journals like Tumor Biology and JCMT. Editorial Board member of JUMD, and many professional societies like ASCO and  ISOBM. He was the director of ISOBM (International society of oncology and biomarkers) 2016 congress held in Chicago and also the member of Organizing Committee for the upcoming ISOBM 2017 congress which will be hosted in  Brazil. He is an expert in Botulinum Toxin and Dermal Fillers, facial reconstruction and hair transplant procedures from Ohio,USA and Poland. He also contributed as an Organizing committee of 14th and upcoming 15th Transitional medicine and oncologist meet, San Francisco, CA.

Research Interest:

Head & neck, lung & upper aerodigestive tumors, tumor stem cells. Nitric oxide in the tumor environment.

Recent Publications:

Expression of cross-tolerance to a wide range of conditions in a human lung cancer cell line after adaptation to nitric oxide

Publishing Journal: Tumor Biology, SAGE


Read full article

A Case of Cytomegalovirus (CMV) Vasculitis Presenting as Deep Venous
Thrombosis with Pulmonary Embolism (DVT/PE) Managed with Catheter
Directed Thrombolysis
Read full article

A rare case of delayed chronic pneumonitis following non-medical grade silicone injections in a transgender woman

Read full article

Book Published:

Volume II Chapter 19 Role of Phospholipases in Cell Death

Publisher: Oct 2018, Wiley-Blackwell

ISBN: 978-1-119-43242-5

To be published:

Current Research:

Gene Network of interest

Complex Gene Network










TCGA Analysis:

TCGA Clinical data analysis


Read Full Resume



IMG 0970 IMG 6009 IMG 6017 IMG 4974 IMG 6749 IMG 4981 IMG 6747 IMG 6742 media 3 Media2 media6 Media1 Media4 media 5 media7 IMG 7783 IMG 0532 IMG 0552 IMG 4810 IMG 0590


Ask me if you have any question.

Address: Chicago,IL
Mail: juel@oncomarks.org

Thank you for your message. We will try to answer as soon as possible